Michael Patrick Miller - 07 Nov 2023 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: Director
Signature: /s/ Gordon Esplin as attorney-in-fact for Michael P. Miller
Issuer symbol: PBYI
Transactions as of: 07 Nov 2023
Transactions value $: -$70,803
Form type: 4
Filing time: 09 Nov 2023, 16:19:04 UTC
Previous filing: 28 Jun 2023
Next filing: 11 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	Common Stock	Sale	-$70.8K	-25K	-36.57%	$2.83	43.4K	07 Nov 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.7801 to $2.8801, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.7801 to $2.8801, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.